Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes
Article first published online: 23 JUN 2011
© 2011 The Association for the Publication of the Journal of Internal Medicine
Journal of Internal Medicine
Volume 270, Issue 4, pages 346–355, October 2011
How to Cite
Forsblom, C., Thomas, M. C., Moran, J., Saraheimo, M., Thorn, L., Wadén, J., Gordin, D., Frystyk, J., Flyvbjerg, A., Groop, P.-H. and on behalf of the FinnDiane Study Group (2011), Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes. Journal of Internal Medicine, 270: 346–355. doi: 10.1111/j.1365-2796.2011.02406.x
- Issue published online: 19 SEP 2011
- Article first published online: 23 JUN 2011
- Accepted manuscript online: 26 MAY 2011 11:21AM EST
Figure S1. Distribution of serum adiponectin concentrations in patients with type 1 diabetes (n = 2034).
Figure S2. The non-linear association between HbA1c (a) and triglycerides (b) with all cause mortality in Finnish adults with type 1 diabetes.
Table S1. Baseline clinical characteristics of 2034 patients with type 1 diabetes from the FinnDiane study without ESKD, stratified according to all-cause mortality.
Table S2. Variables independently associated with all-cause mortality in patients with type 1 diabetes without overt nephropathy from the FinnDiane cohort in a Cox regression model.
|JOIM_2406_sm_FigS1.ppt||53K||Supporting info item|
|JOIM_2406_sm_FigS2.ppt||127K||Supporting info item|
|JOIM_2406_sm_TableS1.doc||40K||Supporting info item|
|JOIM_2406_sm_tableS2.pdf||49K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.